Peritonsillar Phlegmon: An Addition to the Spectrum of COVID-19
Open Access
- 29 December 2020
- journal article
- research article
- Published by Springer Nature in Cureus
- Vol. 12 (12)
Abstract
The coronavirus disease 2019 (COVID-19) epidemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was first reported in December 2019 in Wuhan, China, then declared to be a pandemic associated with substantial morbidity and mortality. It has shown to exhibit a vast array of symptoms, among which fever, shortness of breath, and cough are the most commonly reported. Lymphadenopathy and tonsillar enlargement is a less common finding reported with this infection. This case describes a patient with tonsillar inflammation which was complicated by peritonsillar phlegmon, with negative throat culture and positive COVID-19 test, suggesting a COVID-19-related etiology of the disease. After the literature search, to the best of our knowledge, this is the first reported case of COVID-related peritonsillar inflammation and phlegmon formation.Keywords
This publication has 7 references indexed in Scilit:
- Mediastinal lymphadenopathy in patients with severe COVID-19The Lancet Infectious Diseases, 2020
- Parotitis-Like Symptoms Associated with COVID-19, France, March–April 2020Emerging Infectious Diseases, 2020
- ENT manifestation in COVID-19 patientsAuris Nasus Larynx, 2020
- Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive studyThe Lancet Infectious Diseases, 2020
- Novel Coronavirus: What Neuroradiologists as Citizens of the World Need to KnowAmerican Journal of Neuroradiology, 2020
- PerspectivesAmerican Journal of Neuroradiology, 2020
- Diagnosis and Management of Group A Streptococcal Pharyngitis: A Practice GuidelineClinical Infectious Diseases, 1997